Henry A. Glick

Henry A. Glick, Ph.D. received an M.A. and Ph.D. in Public Policy Analysis from the University of Pennsylvania. He has more then 25 years of experience conducting economic assessments of medical therapies. He specializes in economic evaluations conducted as part of clinical trials. He also has extensive experience with decision analysis, preference assessment, analysis of observational data, and the evaluation of diagnostic tests.

Henry is the head of the economics core of REVIVE-IT, an NHLBI trial evaluating left ventricular assist devices. He also is serving on the second ISPOR Randomized Clinical Trial-Cost Effectiveness Analysis (RCT-CEA) Task Force and has previously served on ISPOR's Task Force on Good Research Practices on Transferability of Economic Data in Health Technology Assessment and its first RCT cost-effectiveness analysis task force.

He has co-taught two classes at the University of Pennsylvania since 1986: “Clinical Economics and Clinical Decision Making” as part of the Masters of Clinical Epidemiology program in the School of Medicine and “Cost Benefit and Cost Effectiveness Analysis in Healthcare” as part of the Ph.D. program in Wharton’s Health Care Systems Department. He teaches a Pharmacoeconomics course at the Food and Drug Administration and regularly leads short courses in methods for economic assessments in clinical trials.

Henry has published over 140 peer-reviewed articles, editorials, reviews, and book chapters.He is the lead author of both Economic Evaluation in Clinical Trials (Oxford University Press, 2007) and its second edition (OUP, 2015). He has written extensively about methods for conducting economic assessments and estimated the value for the cost of therapies in areas such as heart failure, stroke, cancer, major infections, nutritional support, and weight loss. His work has appeared in journals such as Health Economics, Health Services Research, Medical Care, Medical Decision Making, Statistics in Medicine, Pediatrics, the Annals of Internal Medicine, JAMA, and NEJM. He also serves on the editorial board of the American Journal of Managed Care.